Sökresultat

Filtyp

Din sökning på "julie" gav 4779 sökträffar

Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Incidence rates of differentiated thyroid carcinoma (TC) have increased in many countries. Adiposity and dietary risk factors may play a role, but little is known on the influence of energy intake and macronutrient composition. The aim of this study is to investigate associations between TC and the intake of energy, macronutrients, glycemic index (GI) and glycemic load in the European Prospective

Blood Metabolic Signatures of Body Mass Index : A Targeted Metabolomics Study in the EPIC Cohort

Metabolomics is now widely used to characterize metabolic phenotypes associated with lifestyle risk factors such as obesity. The objective of the present study was to explore the associations of body mass index (BMI) with 145 metabolites measured in blood samples in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Metabolites were measured in blood from 392 men from t

Thyroid-Stimulating Hormone, Thyroglobulin, and Thyroid Hormones and Risk of Differentiated Thyroid Carcinoma: The EPIC Study

Background Increased levels of thyroglobulin (Tg) and thyroid-stimulating hormone (TSH) are associated with differentiated thyroid carcinoma (TC) risk, but strong epidemiological evidence is lacking. Methods Three hundred fifty-seven incident TC case patients (n = 300 women and 57 men; mean age at blood collection = 51.5 years) were identified in the EPIC cohort study and matched with 2 (women) or

Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition

Background: The mechanisms underlying the obesity-cancer relationship are incompletely understood. This study aimed to characterise metabolic signatures of greater body size and to investigate their association with two obesity-related malignancies, endometrial and colorectal cancers, and with weight loss within the context of an intervention study. Methods: Targeted mass spectrometry metabolomics

Lymphatic Disorder Management in Pediatric Patients With Congenital Heart Disease in European Pediatric Cardiology Centers : Current Status, Disparities, and Future Considerations

BACKGROUND: Lymphatic disorders such as protein-losing enteropathy, plastic bronchitis, and chylothorax are important complications of the Fontan circulation and ultimately result in an increased risk of early death. Several European centers are now performing lymphatic procedures. The aim of this study is to map the extent of these lymphatic disorders and treatments provided across European pedia

Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes

Genetic studies promise to provide insight into the molecular mechanisms underlying type 2 diabetes (T2D). Variants associated with T2D are often located in tissue-specific enhancer clusters or super-enhancers. So far, such domains have been defined through clustering of enhancers in linear genome maps rather than in three-dimensional (3D) space. Furthermore, their target genes are often unknown.

Consumption of nuts and seeds and pancreatic ductal adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition

Four epidemiologic studies have assessed the association between nut intake and pancreatic cancer risk with contradictory results. The present study aims to investigate the relation between nut intake (including seeds) and pancreatic ductal adenocarcinoma (PDAC) risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Cox proportional hazards models were used to estim

Dietary methyl-group donor intake and breast cancer risk in the european prospective investigation into cancer and nutrition (EPIC)

(1) Background: Methyl-group donors (MGDs), including folate, choline, betaine, and methionine, may influence breast cancer (BC) risk through their role in one-carbon metabolism; (2) Methods: We studied the relationship between dietary intakes of MGDs and BC risk, adopting data from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort; (3) Results: 318,686 pre-and postmen

The EffecTs of Amlodipine and other Blood PREssure Lowering Agents on Microvascular FuncTion in Small Vessel Diseases (TREAT-SVDs) trial : Study protocol for a randomised crossover trial

Background: Hypertension is the leading modifiable risk factor for cerebral small vessel diseases (SVDs). Yet, it is unknown whether antihypertensive drug classes differentially affect microvascular function in SVDs. Aims: To test whether amlodipine has a beneficial effect on microvascular function when compared to either losartan or atenolol, and whether losartan has a beneficial effect when comp

Rapport vecka37 coss

Rapport vecka 37 (publicerad 2020-09-16) COVID Symptom Study Innehåll Bakgrund 2 Metod 2 Etiskt godkännande 4 Aktuell status 5 10 postnummerområden med högst andel studiedeltagare med symtom överensstämmande med covid-19 den 14 september . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 10 postnummerområden med lägst andel studiedeltagare med symtom överensstämmande med

https://www.covid19app.lu.se/sites/covid19app.lu.se/files/rapport_vecka37_coss.pdf - 2025-06-29

Rapport vecka39 coss

Rapport vecka 39 (publicerad 2020-09-30) COVID Symptom Study Innehåll Bakgrund 2 Metod 2 Etiskt godkännande 5 Aktuell status 5 10 postnummerområden med högst andel studiedeltagare med symtom överensstämmande med covid-19 den 28 september . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 10 postnummerområden med lägst andel studiedeltagare med symtom överensstämmande med

https://www.covid19app.lu.se/sites/covid19app.lu.se/files/rapport_vecka39_coss.pdf - 2025-06-29

Rapport vecka40 coss

Rapport vecka 40 (publicerad 2020-10-07) COVID Symptom Study Innehåll Bakgrund 2 Metod 2 Etiskt godkännande 5 Aktuell status 5 10 postnummerområden med lägst andel studiedeltagare med symtom överensstämmande med covid-19 den 5 oktober . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Störst ökning senaste 7 dagarna . . . . . . . . . . . . . . . . . . . . . . . . . .

https://www.covid19app.lu.se/sites/covid19app.lu.se/files/rapport_vecka40_coss.pdf - 2025-06-29

Rapport vecka42 coss

Rapport vecka 42 (publicerad 2020-10-21) COVID Symptom Study Innehåll Bakgrund 2 Metod 2 Etiskt godkännande 5 Aktuell status 5 10 postnummerområden med lägst andel studiedeltagare med symtom överensstämmande med covid-19 den 19 oktober . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Störst ökning senaste 7 dagarna . . . . . . . . . . . . . . . . . . . . . . . . . .

https://www.covid19app.lu.se/sites/covid19app.lu.se/files/rapport_vecka42_coss.pdf - 2025-06-29

Rapport vecka46 coss

Rapport vecka 46 (publicerad 2020-11-18) COVID Symptom Study Innehåll Bakgrund 2 Metod 2 Etiskt godkännande 5 Aktuell status 5 10 postnummerområden med högst andel studiedeltagare med symtom överensstämmande med covid-19 den 16 november . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 10 postnummerområden med lägst andel studiedeltagare med symtom överensstämmande med

https://www.covid19app.lu.se/sites/covid19app.lu.se/files/rapport_vecka46_coss.pdf - 2025-06-29

Rapport vecka36 coss

Rapport vecka 36 (publicerad 2020-09-10) COVID Symptom Study Innehåll Bakgrund 2 Metod 2 Etiskt godkännande 4 Aktuell status 5 10 postnummerområden med högst andel studiedeltagare med symtom överensstämmande med covid-19 den 7 september . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 10 postnummerområden med lägst andel studiedeltagare med symtom överensstämmande med

https://www.covid19app.lu.se/sites/covid19app.lu.se/files/rapport_vecka36_coss.pdf - 2025-06-29

Rapport vecka41 coss

Rapport vecka 41 (publicerad 2020-10-14) COVID Symptom Study Innehåll Bakgrund 2 Metod 2 Etiskt godkännande 5 Aktuell status 5 10 postnummerområden med lägst andel studiedeltagare med symtom överensstämmande med covid-19 den 12 oktober . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Störst ökning senaste 7 dagarna . . . . . . . . . . . . . . . . . . . . . . . . . .

https://www.covid19app.lu.se/sites/covid19app.lu.se/files/rapport_vecka41_coss.pdf - 2025-06-29

Rapport vecka43 coss

Rapport vecka 43 (publicerad 2020-10-28) COVID Symptom Study Innehåll Bakgrund 2 Metod 2 Etiskt godkännande 5 Aktuell status 5 10 postnummerområden med lägst andel studiedeltagare med symtom överensstämmande med covid-19 den 26 oktober . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Störst ökning senaste 7 dagarna . . . . . . . . . . . . . . . . . . . . . . . . . .

https://www.covid19app.lu.se/sites/covid19app.lu.se/files/rapport_vecka43_coss.pdf - 2025-06-29

Delegationsordning EHL 220616

Delegationsordning EHL_220616 Postadress: Box 7080, 220 07 Lund Besöksadress: Tycho Brahes väg 1, Lund Telefon: 046-222 09 54 E-post: alf.rosenback@ehl.lu.se Webbadress: www.ehl.lu.se 1 Fakul tetsstyrelsen Föreskrifter om fördelning av beslutsbefogenheter vid Ekonomihögskolan, Lunds universitet Fastställda av Fakultetsstyrelsen för Ekonomihögskolan 2022-06-16. Dessa föreskrifter träder i kraft den

https://www.lusem.lu.se/internal/sites/lusem.lu.se.internal/files/2024-03/Delegationsordning%20EHL_220616.pdf - 2025-06-29

Allman-studieplan-halsovetenskaper-2016-01-01

Microsoft Word - Allm studieplan hälsovet 2015 .docx   Postadress  Box  117,  221  00    LUND    Telefon  växel  046-­‐222  00  00    Telefax  046-­‐222  41  70       E-­‐post  info@med.lu.se  Internet  http://www.med.lu.se       Medic inska   faku l te tss tyre lsen               Allmän   studieplan   för   utbildning   på   forskarnivå   inom   det   hälsovetenskapliga  området   -­‐  arbetstera

https://www.intramed.lu.se/sites/intramed.lu.se/files/2022-12/allman-studieplan-halsovetenskaper-2016-01-01.pdf - 2025-06-29